In the intermediate to advanced HCC BCLC stages B, C and D the GALAD score was able to discriminate HCC from non-HCC over all etiologies, with an AUC of 0.99, compared to AFP alone with an AUC of 0.91. Here, AFP is linked to hepatocellular carcinoma.